Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Leila Mohassel"'
Publikováno v:
Blood. 140:6158-6159
Publikováno v:
Blood. 138:4572-4572
Introduction: High-dose methotrexate (HD-MTX) requires extensive monitoring and implementation of supportive care strategies to prevent associated toxicities. Although monitoring protocols for MTX vary across institutions, standardized supportive car
Autor:
Leila Mohassel, Lauren Dombrowski
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 25(5)
Obesity continues to be a growing epidemic in the United States. Guidelines published by American Society of Clinical Oncology in 2012 recommend dosing chemotherapy using actual body weight. However, the guidelines do not provide guidance for patient
Autor:
Tom Scaletta, Paul Setlak, Leila Mohassel, Norman Wiginton, Sandra L. Bardas, Richard Thomas, Brenda K. White, Umbreen Idrees, Julie R. McCoy, Keith B. Thomasset, Nancy Bonalumi, Heather Eyrich, James A. Trovato, Fredrick C. Blum, Mary M. Hess, Greene Shepherd, Kenneth Daae, Alexander A. Vinks, Amanda M. Ball, Vincent N. Mosesso, Maria I. Rudis, Matthew J. Geraci, Jim E. Williams, Suzanne Stone-Griffith, Joseph A. Barone, Michael S. Roberts, Teri L. Bair, Helen M. Calmes, Charles G. Durbin, Carol J. Bickford, Robert S. Oakley, Peter J. Zed, Paula J. Mialon, Brian Faley, Kevin O. Rynn, Todd D. Lemke, Stanley S. Kent, Karen D. Gurwitch, Katharine A. Reisbig, Brian K. Werner, Daniel P. Hays, Edward C. Rainville, Lou E. Romig, James R. Rinehart, George Delgado, Gary R. Matzke, Wendy J. Friedig, Jennifer Albrich, Mary T. Meadows
Publikováno v:
American Journal of Health-System Pharmacy. 65:2380-2383
Publikováno v:
Journal of Pain and Symptom Management. 44:e1-e3
Autor:
Lily Leu, Leila Mohassel
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 66(21)
Purpose. The history, clinical pharmacology and toxicities, and role of arsenic trioxide as a first-line agent for treating acute promyelocytic leukemia (APL) are described. Summary. APL is most often characterized by the hallmark reciprocal transloc